The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

Department of Justice

Beleaguered Insys seeks new chief as billionaire Kapoor makes an immediate exit

Mylan crafting new EpiPen sales model as it pushes past pricing mess

Ex-Heritage Pharma execs first up for federal charges in generics price-fixing probe

Need sales compliance training? Check out the Insys indictment for a list of no-no's